Da traduttori professionisti, imprese, pagine web e archivi di traduzione disponibili gratuitamente al pubblico.
open individual export authorization
open individual export authorization
Ultimo aggiornamento 2014-11-21
Frequenza di utilizzo: 1
Qualità:
pid:% 1 (% 2) authorization scope
pid: %1 (%2)
Ultimo aggiornamento 2011-10-23
Frequenza di utilizzo: 1
Qualità:
uma futura aprovação do processo de marketing authorization/new drug application
a future approval of the marketing authorization/new drug application file
Ultimo aggiornamento 2015-01-25
Frequenza di utilizzo: 1
Qualità:
Riferimento:
the exporter of the products covered by this document (customs authorization no ...
the exporter of the products covered by this document (customs authorization no ...
Ultimo aggiornamento 2014-10-23
Frequenza di utilizzo: 2
Qualità:
Riferimento:
marketing authorization holder merck & co., inc whitehouse station, n. j.
marketing authorization holder merck & co., inc whitehouse station, n. j.
Ultimo aggiornamento 2011-10-23
Frequenza di utilizzo: 1
Qualità:
Riferimento:
Attenzione: contiene formattazione HTML nascosta
Attenzione: Questo allineamento potrebbe essere errato.
Eliminalo se ritieni che sia così.
pid de oportunidade única:% 1 (% 2) authorization scope; pid is process id
single shot pid: %1 (%2)
Ultimo aggiornamento 2011-10-23
Frequenza di utilizzo: 1
Qualità:
Riferimento:
distribution of the images in any form is prohibited without the authorization of their legal owner.").
distribution of the images in any form is prohibited without the authorization of their legal owner.".
Ultimo aggiornamento 2016-03-03
Frequenza di utilizzo: 1
Qualità:
Riferimento:
Attenzione: contiene formattazione HTML nascosta
regime de autorização prévia, anteriormente designado regime de licença prévia (advance authorization scheme);
advance authorization scheme (formerly known as advance licence scheme);
Ultimo aggiornamento 2014-11-12
Frequenza di utilizzo: 1
Qualità:
Riferimento:
«national defense authorization act for fiscal year 1993», título xvii — cuban democracy act de 1992, secções 1704 e 1706
‘national defense authorization act for fiscal year 1993’, title xvii ‘cuban democracy act 1992’, sections 1704 and 1706
Ultimo aggiornamento 2017-04-06
Frequenza di utilizzo: 3
Qualità:
Riferimento:
em 1981, o congresso americano adoptou o «the science and technology equal opportunities act/national science foundation authorization act».
in 1981, the united states congress adopted the science and technology equal opportunities act/national science foundation authorisation act.
Ultimo aggiornamento 2017-04-06
Frequenza di utilizzo: 1
Qualità:
Riferimento:
the european communities (authorization, placing on the market, use and control of plant protection products) regulations, 1994, s.
the european communities (authorization, placing on the market, use and control of plant protection products) regulations, 1994, s.i. no. 139 of 1994
Ultimo aggiornamento 2017-04-06
Frequenza di utilizzo: 1
Qualità:
Riferimento:
os integradores que solicitam reparo em garantia devem preencher o seguinte formulário de solicitação de conserto com autorização de devolução direta - dra (direct return authorization).
resellers requesting warranty repair should complete the following dra repair request form.
Ultimo aggiornamento 1970-01-01
Frequenza di utilizzo: 1
Qualità:
Riferimento:
* (article and pictures under gfdl authorization in spanish: :es:wikipedia:autorización cucutanuestra.com).
(article and pictures under gfdl authorization in spanish: :es:wikipedia:autorización cucutanuestra.com)* santiago martinez delgado biography - prelude of the thousand days war
Ultimo aggiornamento 2016-03-03
Frequenza di utilizzo: 1
Qualità:
Riferimento:
a trial of the coronavac shot reported results this week.credit: amanda perobelli/reuters long-awaited results about the effectiveness of a leading chinese covid-19 vaccine were tinged with disappointment and confusion this week. but researchers say the vaccine could help reduce deaths from the disease. researchers in brazil reported that coronavac, developed by beijing-based sinovac, was 50.4% effective at preventing severe and mild covid-19 in late-stage trials. that’s significantly lower than the 90% efficacies of several leading vaccines. the coronavac figures were much lower than those from early trials of the same vaccine in turkey and indonesia, and below the efficacy first reported by the brazil trial team last week. researchers from the butantan institute in são paulo had announced on 7 january that the vaccine’s efficacy was 78% at preventing the disease — but revealed this week that the figure was based on the narrow criteria of people needing medical attention. still, if the latest results check out — they have not been peer reviewed — the two-dose vaccine could be immediately beneficial in countries with raging outbreaks, such as brazil, say researchers. “when you’ve got communities that are absolutely desperate, and have no other choice, then this is a really great thing to have,” says hilda bastian, who studies evidence-based medicine at bond university in the gold coast, australia. the brazil trial recorded 252 cases of covid-19 — 167 in people who received the placebo and 85 who were vaccinated — in some 9,200 healthcare workers. none of the participants who received the vaccine had to be hospitalized with severe covid-19. if the data are confirmed, the vaccine could have a role in preventing disease in every country, says paul offit, a vaccine scientist at the children’s hospital of philadelphia in pennsylvania. flow-on effects brazil’s data are important for turkey, which yesterday began its plan to roll out millions of coronavac doses under an emergency-use authorization announced on 13 january, says murat akova, a clinical infectious-diseases researcher at hacettepe university school of medicine in ankara, who is a coordinator of a late-stage coronavac trial in turkey. delays in brazil’s reporting of trial results meant that turkey relied on early data from its own efficacy trial when it agreed to distribute coronavac, says akova. in late december, the turkey trial reported that coronavac was 91.25% effective at preventing symptomatic disease on the basis of 29 covid-19 cases among 1,322 volunteers. brazil’s results are disappointing when compared with the two rna-based frontrunners, developed by pfizer–biontech and moderna, which were found to be more than 90% effective in trials, says akova. but coronavac is still valuable to turkey because it will prevent most severe cases. indonesia has also authorized coronavac for emergency use and started its national vaccination programme on 13 january. results from an efficacy trial of about 1,600 people in that country found the vaccine was 65.3% effective at preventing symptomatic disease on the basis of 25 covid-19 cases, says jarir at thobari, a vaccinologist at gadjah mada university in yogyakarta, indonesia. given indonesia’s large population, a lot of people could benefit from the vaccine even at 65% effectiveness, he says. scientists say mixed results are not surprising for a vaccine with lower efficacy that has been tested in relatively small numbers of people. mixed results have also been reported from trials of the covid-19 vaccine developed by the university of oxford, uk, and drug firm astrazeneca. “if you’ve got a vaccine with really high efficacy, you don’t need a whole lot of numbers to get a clear picture. but when it’s complicated, then you really need bigger numbers to get a better handle on what’s going on,” says bastian. researchers involved with the brazil trial say the lower efficacy compared with other vaccines could be because the two shots were administered only two weeks apart, which did not leave sufficient time for participants to reach peak immunity. they also say that the trial, which recruited only health professionals, who are more likely to be exposed to the virus, report symptoms and get tested, probably identified more mild infections than did trials in indonesia and turkey, which included the public. the brazilian health regulator, anvisa, will decide whether to approve coronavac and astrazeneca’s vaccine for emergency use on 17 january. some seven million doses of coronavac have already been distributed across china. other benefits the roll out of coronavac, which uses an inactivated version of sars-cov-2 to induce an immune response1, could see more widespread use in other nations, says adrian esterman, a biostatistician at university of south australia in adelaide. compared with the pfizer–biontech vaccine, which must be stored at −70 ºc, coronavac is stable at fridge temperatures and easier to distribute. on the basis of the data reported so far, the vaccine seems safe, with only a few people experiencing mild symptoms such as headache. a world health organization (who) team in china is reviewing manufacturing practices for sinovac’s vaccine, and those produced by chinese state-owned sinopharm. if the who lists the vaccines for emergency use, that will accelerate their global distribution, says bastian.
Ultimo aggiornamento 2021-01-24
Frequenza di utilizzo: 1
Qualità:
Riferimento: